SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS
SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS (CVR number: 32155014) is a company from SVENDBORG. The company reported a net sales of 4 mDKK in 2024, demonstrating a growth of 1.1 % compared to the previous year. The operating profit percentage was at 3.6 % (EBIT: 0.1 mDKK), while net earnings were 117.2 kDKK. The profitability of the company measured by Return on Assets (ROA) was 13.8 %, which can be considered good but Return on Equity (ROE) was 39.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 23.6 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. SPECIALLÆGESELSKABET ØRE-NÆSE-HALSKLINIKKEN MORTEN ROSENKILDE QVIST ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 3 372.19 | 3 573.88 | 3 520.06 | 3 979.68 | 4 023.95 |
Gross profit | 2 784.06 | 2 967.36 | 2 904.13 | 3 329.19 | 3 294.67 |
EBIT | 113.39 | 16.44 | 3.24 | 165.20 | 144.31 |
Net earnings | 126.65 | 127.97 | -31.82 | 170.83 | 117.18 |
Shareholders equity total | 370.36 | 387.73 | 242.91 | 299.34 | 298.72 |
Balance sheet total (assets) | 1 020.98 | 784.66 | 749.99 | 1 273.12 | 1 264.47 |
Net debt | - 502.61 | - 269.23 | - 218.88 | - 179.38 | -25.41 |
Profitability | |||||
EBIT-% | 3.4 % | 0.5 % | 0.1 % | 4.2 % | 3.6 % |
ROA | 15.3 % | 18.7 % | 0.9 % | 23.8 % | 13.8 % |
ROE | 35.0 % | 33.8 % | -10.1 % | 63.0 % | 39.2 % |
ROI | 36.8 % | 39.2 % | 1.7 % | 35.6 % | 16.3 % |
Economic value added (EVA) | 96.63 | 19.46 | -0.24 | 131.67 | 142.77 |
Solvency | |||||
Equity ratio | 36.3 % | 49.4 % | 32.4 % | 23.5 % | 23.6 % |
Gearing | 16.3 % | 32.7 % | 241.6 % | 279.8 % | |
Relative net indebtedness % | 3.7 % | 1.4 % | 5.8 % | 1.8 % | 2.6 % |
Liquidity | |||||
Quick ratio | 1.2 | 1.6 | 1.2 | 1.2 | 1.2 |
Current ratio | 1.2 | 1.6 | 1.2 | 1.2 | 1.2 |
Cash and cash equivalents | 502.61 | 332.60 | 298.39 | 902.49 | 861.10 |
Capital use efficiency | |||||
Trade debtors turnover (days) | 24.9 | 25.5 | 25.9 | 22.9 | 22.7 |
Net working capital % | -7.4 % | -3.0 % | -5.8 % | -4.5 % | -5.8 % |
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BBB | BBB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.